Anti-Human CD25 Therapeutic Antibody (Daclizumab)
Recombinant monoclonal antibody to Human CD25. Daclizumab (trade name daclizumab) is a therapeutic humanized monoclonal antibody. It is used to prevent rejection in organ transplantation, especially in kidney transplants. The drug is also under investigation for the treatment of multiple sclerosis. Daclizumab works by binding to CD25, the alpha subunit of the IL-2 receptor of T cells.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-023 |
| Pricing | Inquiry |
| Host | Mouse |
| Target | CD25 |
| Species Reactivity | Human |
| Type | IgG1 - kappa |
| Applications | ELISA, Neut, IF, IP, FC, FuncS, MRI |
| Storage | Store at -20°C for long-term storage. Store at 2-8°C for up to one month. Avoid freeze/thaw cycles. |